BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22650352)

  • 1. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation.
    Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
    Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
    Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.
    Yin J; Hu H; Wang Y; Xue M; Li X; Cheng W; Li X; Yan S
    Clin Cardiol; 2014 Nov; 37(11):707-15. PubMed ID: 25156448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation.
    Schwartzman D; Housel D; Bazaz R; Jain S; Saba S; Gorcsan J; Adelstein E
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):275-81. PubMed ID: 25431023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction.
    Huang W; Su L; Wu S; Xu L; Xiao F; Zhou X; Ellenbogen KA
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.
    Ganesan AN; Brooks AG; Roberts-Thomson KC; Lau DH; Kalman JM; Sanders P
    J Am Coll Cardiol; 2012 Feb; 59(8):719-26. PubMed ID: 22340263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
    Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
    Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
    Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L;
    Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac resynchronization therapy in patients with permanent atrial fibrillation].
    Mareev IuV; Shitov VN; Kiktev VG; Sapel'nikov OV; Latypov RS; Grishin IR; Malkina TA; Nesterenko LIu; Iuricheva IuA; Sokolov SF; Saidova MA; Akchurin RS; Golitsyn SP
    Kardiologiia; 2013; 53(5):43-9. PubMed ID: 23952994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Tricuspid Regurgitation on the Success of Atrioventricular Node Ablation for Rate Control in Patients With Atrial Fibrillation: The Node Blast Study.
    Reddy YM; Gunda S; Vallakati A; Kanmanthareddy A; Pillarisetti J; Atkins D; Bommana S; Emert MP; Pimentel R; Dendi R; Berenbom LD; Lakkireddy D
    Am J Cardiol; 2015 Sep; 116(6):900-3. PubMed ID: 26174606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Causes of non-response to cardiac resynchronization therapy in heart failure patients with permanent atrial fibrillation].
    Wang DM; Yu HB; Qi SY; Ding C; Wang G; Han YL; Zang HY; Ru LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):757-61. PubMed ID: 23141088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?
    Tolosana JM; Arnau AM; Madrid AH; Macias A; Lozano IF; Osca J; Quesada A; Toquero J; Francés RM; Bolao IG; Berruezo A; Sitges M; Alcalá MG; Brugada J; Mont L;
    Eur J Heart Fail; 2012 Jun; 14(6):635-41. PubMed ID: 22396459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrioventricular nodal ablation is an effective management strategy for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Butcher C; Rajappan S; Wharmby AL; Ullah W; Wong T; Jones D; Rajappan K; Martin C; Elliott P; Gill JS; Specterman M; Dhinoja MB; Sporton S; Lambiase PD; Hunter RJ; Honarbakhsh S
    Heart Rhythm; 2023 Dec; 20(12):1606-1614. PubMed ID: 37633429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.